Goyal Associates (530663)
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1.99 |
| Market Cap | ₹9.46 Cr |
| P/E Ratio | 19.21 |
| ROCE | 17.37% |
| ROE | 6.89% |
| Dividend Yield | 0% |
| Profit Growth | -83.87% |
| Debt/Equity | — |
| Sales Growth | -68.54% |
| 52-Week Range | ₹0.65 — ₹1.99 |
| Sector | Finance |
| Book Value | ₹0.68 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At first glance, this is exactly the kind of situation where I sit on my hands. Goyal Associates is a small NBFC with a market cap of just ₹9 Cr, trading at ₹1.99. The latest quarter shows zero sales and zero profit. Full-year sales are down 68.54% and profits are down 83.87%. That is not a growth story; that is a business shrinking in front of me. Book value is ₹0.68, so I am being asked to pay 2.93 times book for a company whose current earnings power appears to be nil. A P/E of 19.21 means little when the E is collapsing. ROE of 6.89% is mediocre; ROCE of 17.37% looks better but cannot be trusted when latest revenue and profit are zero. The Piotroski F-score of 3 out of 9 reinforces the picture of financial weakness. There is no dividend, no promoter holding data, and no FairStock score—too little transparency for a prudent investor. Graham taught me to buy with a margin of safety. Here, the margin is on the other side: I would be paying a premium to book value for a company with no visible operations. The stock has risen from ₹0.65 to ₹1.99, but price momentum is not investment evidence. I need to see actual sales, actual profit, and a credible path back to health before I risk capital. Until then, this belongs in the 'too hard' pile.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer